These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19012940)

  • 1. Mortality and loss to follow-up among HAART initiators in rural South Africa.
    MacPherson P; Moshabela M; Martinson N; Pronyk P
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):588-93. PubMed ID: 19012940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
    Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
    Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
    Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
    Van der Borght SF; Clevenbergh P; Rijckborst H; Nsalou P; Onyia N; Lange JM; de Wit TF; Van der Loeff MF
    Antivir Ther; 2009; 14(1):63-74. PubMed ID: 19320238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
    Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
    Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in perimortal conditions and mortality rates among HIV-infected patients.
    Hooshyar D; Hanson DL; Wolfe M; Selik RM; Buskin SE; McNaghten AD
    AIDS; 2007 Oct; 21(15):2093-100. PubMed ID: 17885300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmortem findings in HIV/AIDS patients in a tertiary care hospital in rural South Africa.
    Garcia-Jardon M; Bhat VG; Blanco-Blanco E; Stepian A
    Trop Doct; 2010 Apr; 40(2):81-4. PubMed ID: 20305099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.
    Thai S; Koole O; Un P; Ros S; De Munter P; Van Damme W; Jacques G; Colebunders R; Lynen L
    Trop Med Int Health; 2009 Sep; 14(9):1048-58. PubMed ID: 19573140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opportunistic infections. Developments and trends since establishment of HAART therapy].
    Marquardt T; Jablonowski H
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():56-60. PubMed ID: 11373785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and laboratory findings in HIV-infected patients at the Jeanne Ebori Foundation in Libreville, Gabon (2002-2005)].
    Okome Nkoumou MM; Okome Essima R; Obiang Ndong GP; Okome Miame F
    Med Trop (Mars); 2007 Aug; 67(4):357-62. PubMed ID: 17926794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.
    Park BJ; Shetty S; Ahlquist A; Greenbaum A; Miller JL; Motsi A; McCarthy K; Govender N;
    Int J STD AIDS; 2011 Apr; 22(4):199-203. PubMed ID: 21515751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining incidence of intestinal microsporidiosis and reduction in AIDS-related mortality following introduction of HAART in Sydney, Australia.
    van Hal SJ; Muthiah K; Matthews G; Harkness J; Stark D; Cooper D; Marriott D
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1096-100. PubMed ID: 17662322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient retention and attrition on antiretroviral treatment at district level in rural Malawi.
    Massaquoi M; Zachariah R; Manzi M; Pasulani O; Misindi D; Mwagomba B; Bauernfeind A; Harries AD
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):594-600. PubMed ID: 19298993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa.
    Kakinami L; de Bruyn G; Pronyk P; Mohapi L; Tshabangu N; Moshabela M; McIntyre J; Martinson NA
    AIDS Behav; 2011 May; 15(4):823-31. PubMed ID: 20703794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
    Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
    J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-related mortality among tuberculosis patients in The Netherlands, 1993-2001.
    Haar CH; Cobelens FG; Kalisvaart NA; van Gerven PJ; van der Have JJ
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):1038-41. PubMed ID: 17918662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
    Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
    Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and acceptability of HAART among TB patients in Durban, South Africa.
    Gebrekristos HT; Lurie MN; Mthethwa N; Karim QA
    AIDS Care; 2005 Aug; 17(6):767-72. PubMed ID: 16036263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.